RadarScreener › SKYE

SKYE

Skye Bioscience, Inc.
SKYE stock: dilution, delisting risk, reverse split — what the SEC filings say, updated every weekday morning.
Nasdaq · Pharmaceutical Preparations · EDGAR filings (CIK 1516551) · 18 signals · 3 setups · updated Sep 18, 2026

What the filings say Pressure ▼

The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K.

Radar 93 (high attention) · dilution pressure high · listing risk high · governance risk elevated · runway 3.8 mo · strongest signal: Exchange deficiency notice (Aug 19, 2026)

What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

Get tomorrow's read on SKYE — free
One email every weekday morning: what changed across SKYE and ~1,400 other microcaps, every claim linked to the filing.
93Radar · attention score (0–100)
82Dilution pressure · financing + balance sheet
92Listing risk · exchange standards
60Governance risk · reporting, auditor, going concern

Setups

Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.

Forced-raise setup Pressure ▼ strength 0.95

The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (negative equity, runway < 6 months) coexists with live selling machinery (equity line, pipe). Base case is a discounted raise; the question is when, not if.

Would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
Would invalidate: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Equity lineNegative equityPIPERunway < 6 months

Listing cliff Pressure ▼ strength 0.80

Listing is at risk and the usual cures are constrained. Next thing to watch: a reverse-split proxy, a hearings-panel 8-K, or a Form 25. Exchange deficiency plus a structural reason cure is hard (sub-$5M float, negative equity, no cash, or a reverse split already used). Under Nasdaq's 2026 rules (one reverse split per 12 months; $5M MVLS floor with no cure period from Sept 2026) the usual escape hatches are narrower.

Would confirm: Nasdaq 'Pending Suspension' listing, Form 25, hearings-panel denial 8-K, or a reverse-split proxy.
Would invalidate: 8-K announcing regained compliance; equity raise that restores stockholders' equity; MVLS back above threshold for 10+ days.
Delisting languageEquity deficiencyExchange deficiency noticeMinimum bid deficiencyNegative equityReverse splitRunway < 6 months

Death-spiral watch Pressure ▼ strength 0.70

Variable-priced paper is outstanding while the listing is under stress — the structure where dilution can accelerate. Watch the share count each quarter. Discount-priced or variable-priced securities are outstanding while the company is managing its listing with reverse splits/notices. Each conversion lowers the price, which lowers the next conversion price.

Would confirm: Rising share count in 10-Q cover vs prior quarter; repeated 424B3 resales; another reverse split proposal.
Would invalidate: Notes repaid in cash / equity line terminated (8-K 1.02); share count flat quarter over quarter.
Delisting languageEquity deficiencyEquity lineExchange deficiency noticeMinimum bid deficiencyReverse split

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on SKYE
Alerts
One email the morning SKYE files anything that matches your rules (types, minimum score, setups).
12-month history
Every signal and setup for SKYE back a year, not just 30 days — see how the current setup built.
Full analyst notes
What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV
All 910 flagged companies, same-day, sortable and exportable.
Get Pro · $18.85/mo founding rate   See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$8.1Mcash + short-term investments as of Jun 30, 2026
3.8 moestimated runway (annualized 180-day YTD operating cash flow [companyfacts])
$-497Kstockholders' equity as of Jun 30, 2026
$129.5Mpublic float (10-K cover)
35.4Mshares outstanding as of Aug 10, 2026 · was 35.1M May 8, 2026

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 80 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

DateSignalEvidenceScore
Sep 11, 2026 Minimum bid deficiency “min bid” language in 8-K (8-K) filed 2026-09-11 filing 39
Sep 11, 2026 Material agreement terminated 8-K Item 1.02 filed 2026-09-11 (accepted 16:13 ET) filing 37
Sep 11, 2026· Officer/director change 8-K Item 5.02 filed 2026-09-11 (accepted 16:13 ET) filing 24
Aug 24, 2026 Equity line “equity line” language in 8-K (EX-10.1) filed 2026-08-24 filing 52
Aug 24, 2026 Equity deficiency “stockholders equity deficiency” language in 8-K (EX-10.1) filed 2026-08-24 filing 42
Aug 24, 2026 PIPE “pipe” language in 8-K (EX-10.1) filed 2026-08-24 filing 38
Aug 24, 2026 Unregistered sale 8-K Item 3.02 filed 2026-08-24 (accepted 16:02 ET) filing 37
Aug 24, 2026 Reverse split “reverse split” language in 8-K (8-K) filed 2026-08-24 filing 34
Aug 24, 2026 Delisting language “delisting notice” language in 8-K (EX-10.1) filed 2026-08-24 filing 32
Aug 20, 2026 Minimum bid deficiency “min bid” language in 8-K/A (8-K/A) filed 2026-08-20 filing 39
Aug 20, 2026 Reverse split “reverse split” language in 8-K/A (8-K/A) filed 2026-08-20 filing 34
Aug 20, 2026 Holder rights modified 8-K Item 3.03 filed 2026-08-20 (accepted 21:42 ET) filing 30
Aug 19, 2026 Exchange deficiency notice 8-K Item 3.01 filed 2026-08-19 (accepted 19:56 ET) filing 55
Aug 19, 2026 Equity deficiency “stockholders equity deficiency” language in 8-K (8-K) filed 2026-08-19 filing 52
Aug 19, 2026 Delisting language “delisting notice” language in 8-K (8-K) filed 2026-08-19 filing 46
Aug 19, 2026 Reverse split “reverse split” language in 8-K (8-K) filed 2026-08-19 filing 34
Jun 30, 2026 Runway < 6 months ~3.8 months runway: liquidity $10,064,141 (cash $8,068,357 + investments $1,995,784) as of 2026-06-30, burn $31,794,726/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing 37
Jun 30, 2026 Negative equity Stockholders' equity $-497,307 as of 2026-06-30 filing 31

Other forced raise setups

AUID authID Inc. · SOBR SOBR Safe, Inc. · SDST Stardust Power Inc. · ADIL ADIAL PHARMACEUTICALS, INC. · GOVX GeoVax Labs, Inc. · MYSZ My Size, Inc. · screener →

Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans